Ovarian Cancer section

Ovarian Cancer News & Features

Two genes that trigger most severe form of ovarian cancer are pinpointed

Two genes that trigger most severe form of ovarian cancer are pinpointed

Investigators have created the first mouse model of the worst form of ovarian cancer and found a potential route to both improved treatments and much-needed diagnostic screens.

Even short-term hormone replacement therapy use associated with increased ovarian cancer risk

Even short-term hormone replacement therapy use associated with increased ovarian cancer risk

Women who use hormone replacement therapy for just a few years have an approximately 40% higher risk of developing ovarian cancer.

Maximum tolerated doses of gemcitabine

Maximum tolerated doses of gemcitabine

How much more toxicity and myelosuppression has been associated with gemcitabine (Gemzar) when it is infused over periods longer than 30 minutes?

Targeting microRNA may benefit some patients with ovarian and breast cancer

Researchers believe they may have found a molecule-based approach to halting the destructive quality of the 3q26.2 amplicon, a frequent chromosomal aberrations seen in many cancers, including ovarian and breast cancers.

FDA approves lynparza to treat advanced ovarian cancer

FDA approves lynparza to treat advanced ovarian cancer

For advanced ovarian cancer associated with defective BRCA genes

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs